M-300

N/A

Report date: 2024/12/10 15:07:42

First In Class

Base Information

Drug NameM-300

Drug Alias NameM-300M300

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 3 agonists

TargetsTumor necrosis factor receptor superfamily member 3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesMestag Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesMestag Therapeutics Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A